Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes.
Zaazouee MS, Hamdallah A, Helmy SK, Hasabo EA, Sayed AK, Gbreel MI, Elmegeed AA, Aladwan H, Elshanbary AA, Abdel-Aziz W, Elshahawy IM, Rabie S, Elkady S, Ali AS, Ragab KM, Nourelden AZ.
Zaazouee MS, et al. Among authors: hamdallah a.
Diabetes Metab Syndr. 2022 Jun;16(6):102511. doi: 10.1016/j.dsx.2022.102511. Epub 2022 May 20.
Diabetes Metab Syndr. 2022.
PMID: 35623229